Autres langues MYND Life Sciences Inc.

Actions

MYND

CA62857B1094

Marché Fermé - Canadian Securities Exchange Autres places de cotation 21:09:47 30/04/2024			Varia. 5j.	Varia. 1 janv.
0,035 ^CAD	-.--%		+16,67%	-12,50%

21/03	MYND Life Sciences Inc. annonce ses résultats pour le premier trimestre clos le 31 janvier 2024	CI
04/03	MYND Life Sciences Inc. annonce ses résultats pour l'exercice clos le 31 octobre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024	21/03
MYND Life Sciences Inc. Reports Earnings Results for the Full Year Ended October 31, 2023	04/03
MYND Life Sciences Inc. Appoints Laurie Bakke as an Independent Non-Executive Director	30/01
MYND Life Sciences Announces New Director & Update on the Proposed Merger with Cava Healthcare Inc.	30/01
Mynd Announces Transition of Dr. Lyle Oberg, E.C.A. to Executive Chairman from the Role of CEO	06/12
Mynd Announces Transition of Dr. Lyle Oberg, E.C.A. from the Role of CEO to Executive Chairman	06/12
MYND Life Sciences Inc. Appoints Mr. John Campbell as Chief Executive Officer	06/12
MYND Life Sciences Inc. Appoints John Campbell as President	06/12
MYND Life Sciences Inc. Announces the Appointment of Mr. John Campbell as President and Chief Executive Officer	06/12
Dr. Lyle Oberg Appointment as Board Chair of Alberta Health Services and Executive Chair of MYND Life Sciences	04/12
MYND Life Sciences Inc. Announces Non-Binding LOI to enable merger with Cava Healthcare Inc.	26/10/23
MYND Life Sciences Inc. entered into a non-binding letter of intent to acquire Cava Healthcare Inc.	25/10/23
MYND Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023	19/09/23
MYND Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023	29/06/23
MYND Life Sciences Inc. Reports Earnings Results for the First Quarter Ended January 31, 2023	05/05/23
MYND Life Sciences Inc. Auditor Raises 'Going Concern' Doubt	28/04/23
MYND Life Sciences Inc. Reports Earnings Results for the Full Year Ended October 31, 2022	28/04/23
MYND Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022	28/09/22
VMYND Lifesciencs Inc. cancelled the acquisition of Tidal Psychedelics.	29/06/22
MYND Life Sciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022	23/06/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues MYND Life Sciences Inc.

Actions

MYND

CA62857B1094

Autres langues

Filtres